|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM160673585 |
003 |
DE-627 |
005 |
20250207030041.0 |
007 |
tu |
008 |
231223s2006 xx ||||| 00| ||eng c |
028 |
5 |
2 |
|a pubmed25n0536.xml
|
035 |
|
|
|a (DE-627)NLM160673585
|
035 |
|
|
|a (NLM)16473551
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Fuentes, P
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Inhibition of in vitro gamete adhesion and in vivo fertility in mice by immunization with a synthetic peptide
|
264 |
|
1 |
|c 2006
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
500 |
|
|
|a Date Completed 31.05.2006
|
500 |
|
|
|a Date Revised 20.11.2014
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a PROBLEM: To evaluate the contraceptive ability of a synthetic peptide in in vitro and in vivo fertility in the mouse
|
520 |
|
|
|a METHOD OF STUDY: A synthetic peptide segment: GELRERAPGQGTNG (SP) was used to immunize female B6CF1 (C57BL/6 x BALB/c) mice. A peptide with an amino acid sequence QQPLSIQQHERG (p2control) was used as control. Anti-SP and anti-p2control antisera were used to evaluate sperm function inhibition in vitro. Fertility of immunized mice was determined by microscopic evaluation of the number and state of preimplantation embryos (8-16 cell stage)
|
520 |
|
|
|a RESULTS: In the mouse, anti-SP antisera recognized surface antigens in the acrosome region of mature and capacitated sperm. Anti-SP antisera inhibited in vitro sperm binding to zona pellucida. In vivo, immune response against SP in Freund's adjuvant resulted in a significant increase (P < 0.01) in the number of dead embryos and eggs (a mean of 66%, in contrast with < 25% in control mice). Fertility inhibition in vivo and in vitro was not observed when the p2control peptide was used in the immunizations
|
520 |
|
|
|a CONCLUSIONS: These results would suggest that the SP sequence is involved in gamete adhesion, and an antifertility vaccine against the SP peptide segment could be feasible
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
7 |
|a Antibodies
|2 NLM
|
650 |
|
7 |
|a Immune Sera
|2 NLM
|
650 |
|
7 |
|a Peptides
|2 NLM
|
700 |
1 |
|
|a Palacio, J R
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Mayorga, M
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Martínez, P
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 119(2006), 2 vom: 15. Mai, Seite 195-202
|w (DE-627)NLM098196855
|x 1521-6616
|7 nnns
|
773 |
1 |
8 |
|g volume:119
|g year:2006
|g number:2
|g day:15
|g month:05
|g pages:195-202
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 119
|j 2006
|e 2
|b 15
|c 05
|h 195-202
|